Symbols / ADXN $5.72 +0.00% Addex Therapeutics Ltd

Healthcare • Biotechnology • Switzerland • NCM
ADXN Chart
About

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM); and GABAB PAM for the treatment pain, anxiety, addiction, cough, and overactive bladder. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the develop mGlu2 PAM compounds for the treatment of human health; and license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 7.05M
Enterprise Value 664.58M Income -6.20M Sales 158.54K
Book/sh 0.06 Cash/sh 0.02 Dividend Yield —
Payout 0.00% Employees 2 IPO —
P/E — Forward P/E -114.39 PEG —
P/S 44.45 P/B 89.47 P/C —
EV/EBITDA -270.50 EV/Sales 4191.93 Quick Ratio 1.91
Current Ratio 2.01 Debt/Eq 0.61 LT Debt/Eq —
EPS (ttm) -9.02 EPS next Y -0.05 EPS Growth —
Revenue Growth -15.00% Earnings — ROA -15.90%
ROE -72.84% ROIC — Gross Margin 0.00%
Oper. Margin -14.04% Profit Margin 0.00% Shs Outstand 1.23M
Shs Float 92.72M Short Float 1.04% Short Ratio 3.88
Short Interest — 52W High 12.05 52W Low 5.57
Beta 1.86 Avg Volume 5.37K Volume 7.00
Target Price — Recom None Prev Close $5.72
Price $5.72 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$6.04
Latest analyst target
3. DCF / Fair value
$-8.76
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$6.04
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-07-31 up HC Wainwright & Co. Neutral → Buy $30
News
RSS: Latest ADXN news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.40
-74.95%
1.61
+13.39%
1.42
-51.22%
2.92
Operating Revenue
0.40
-74.95%
1.61
+13.39%
1.42
-51.22%
2.92
Operating Expense
3.16
-18.07%
3.86
-67.77%
11.96
-35.06%
18.42
Research And Development
0.44
-53.84%
0.94
-88.04%
7.88
-12.54%
9.01
Selling General And Administration
1.68
-17.52%
2.03
-37.74%
3.26
-57.89%
7.75
General And Administrative Expense
1.68
-17.52%
2.03
-37.74%
3.26
-57.89%
7.75
Salaries And Wages
0.24
+1.70%
0.24
-5.75%
0.25
-94.66%
4.74
Other Gand A
1.21
+3.69%
1.16
-17.91%
1.42
+2.75%
1.38
Other Operating Expenses
0.86
-1.63%
0.87
+7.60%
0.81
-38.45%
1.31
Total Expenses
3.16
-18.07%
3.86
-67.77%
11.96
-35.06%
18.42
Operating Income
-2.76
-22.84%
-2.24
+78.72%
-10.54
+32.02%
-15.51
Total Operating Income As Reported
-2.76
-22.84%
-2.24
+78.72%
-10.54
+32.02%
-15.51
EBITDA
-4.65
-112.10%
-2.19
+79.05%
-10.45
+30.04%
-14.94
Normalized EBITDA
-4.66
-148.96%
-1.87
+81.62%
-10.19
+32.76%
-15.15
Reconciled Depreciation
0.26
-14.98%
0.31
-5.32%
0.32
-7.04%
0.35
EBIT
-4.91
-96.52%
-2.50
+76.83%
-10.78
+29.52%
-15.29
Total Unusual Items
0.02
+105.49%
-0.32
-20.02%
-0.26
-224.88%
0.21
Total Unusual Items Excluding Goodwill
0.02
+105.49%
-0.32
-20.02%
-0.26
-224.88%
0.21
Net Income
7.06
+166.84%
-10.56
+49.26%
-20.80
-35.52%
-15.35
Pretax Income
-4.91
-96.36%
-2.50
+76.86%
-10.80
+29.62%
-15.35
Net Non Operating Interest Income Expense
0.01
-90.65%
0.06
+4505.29%
0.00
+102.26%
-0.06
Interest Expense Non Operating
0.00
-8.23%
0.00
-86.17%
0.03
-55.65%
0.06
Net Interest Income
0.01
-90.65%
0.06
+4505.29%
0.00
+102.26%
-0.06
Interest Expense
0.00
-8.23%
0.00
-86.17%
0.03
-55.65%
0.06
Interest Income Non Operating
0.01
-85.67%
0.06
+118.67%
0.03
+449.62%
0.01
Interest Income
0.01
-85.67%
0.06
+118.67%
0.03
+449.62%
0.01
Other Income Expense
-2.16
-580.69%
-0.32
-20.02%
-0.26
-224.88%
0.21
Gain On Sale Of Security
0.02
+105.49%
-0.32
-20.02%
-0.26
-224.88%
0.21
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
7.06
+166.84%
-10.56
+49.26%
-20.80
-35.52%
-15.35
Net Income From Continuing Operation Net Minority Interest
-4.91
-96.36%
-2.50
+76.86%
-10.80
+29.62%
-15.35
Net Income From Continuing And Discontinued Operation
7.06
+166.84%
-10.56
+49.26%
-20.80
-35.52%
-15.35
Net Income Continuous Operations
-4.91
-96.36%
-2.50
+76.86%
-10.80
+29.62%
-15.35
Net Income Discontinuous Operations
11.97
+248.52%
-8.06
+19.44%
-10.00
—
Normalized Income
-4.93
-125.70%
-2.18
+79.29%
-10.54
+32.28%
-15.56
Net Income Common Stockholders
7.06
+166.84%
-10.56
+49.26%
-20.80
-35.52%
-15.35
Diluted EPS
8.40
+150.00%
-16.80
+69.57%
-55.20
-2.22%
-54.00
Basic EPS
8.40
+150.00%
-16.80
+69.57%
-55.20
-2.22%
-54.00
Basic Average Shares
0.82
+32.04%
0.62
+64.45%
0.38
+32.43%
0.28
Diluted Average Shares
1.40
+13.18%
1.23
+80.13%
0.69
+141.02%
0.28
Diluted NI Availto Com Stockholders
7.06
+166.84%
-10.56
+49.26%
-20.80
-35.52%
-15.35
Depreciation Amortization Depletion Income Statement
0.19
+1539.70%
0.01
+33.33%
0.01
-97.46%
0.35
Depreciation And Amortization In Income Statement
0.19
+1539.70%
0.01
+33.33%
0.01
-97.46%
0.35
Depreciation Income Statement
0.19
+1539.70%
0.01
+33.33%
0.01
-97.46%
0.35
Earnings From Equity Interest
-2.18
0.00
0.00
—
Insurance And Claims
0.23
-64.08%
0.63
-60.50%
1.59
-0.04%
1.59
Rent And Landing Fees
—
0.04
-24.78%
0.05
+26.05%
0.04
Rent Expense Supplemental
—
0.04
-24.78%
0.05
+26.05%
0.04
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
10.68
+130.04%
4.64
-43.95%
8.28
-63.26%
22.54
Current Assets
3.54
-16.37%
4.23
-45.91%
7.83
-64.32%
21.94
Cash Cash Equivalents And Short Term Investments
3.35
-13.40%
3.87
-44.45%
6.96
-66.05%
20.50
Cash And Cash Equivalents
3.34
-13.55%
3.87
-44.44%
6.96
-66.04%
20.48
Cash Financial
3.34
-13.55%
3.87
-44.44%
6.96
-66.04%
20.48
Other Short Term Investments
0.01
+666.04%
0.00
-73.21%
0.00
-81.54%
0.02
Receivables
0.02
-89.74%
0.15
-74.72%
0.60
+84.43%
0.32
Accounts Receivable
0.02
-85.94%
0.11
-73.53%
0.42
+152.98%
0.16
Other Receivables
—
0.04
-77.45%
0.18
+13.66%
0.16
Prepaid Assets
0.17
-21.82%
0.22
-19.74%
0.27
-75.76%
1.12
Current Deferred Assets
—
—
—
0.00
Other Current Assets
0.01
—
—
—
Total Non Current Assets
7.14
+1652.34%
0.41
-10.11%
0.45
-24.49%
0.60
Net PPE
0.04
-87.90%
0.35
-11.49%
0.40
-26.45%
0.54
Gross PPE
0.20
-95.80%
4.67
+5.89%
4.41
+2.28%
4.32
Accumulated Depreciation
-0.15
+96.44%
-4.32
-7.62%
-4.02
-6.41%
-3.77
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.00
-100.00%
0.01
+0.00%
0.01
+0.00%
0.01
Other Properties
0.08
-97.12%
2.94
+0.23%
2.94
-2.48%
3.01
Leases
0.11
-93.53%
1.73
+17.21%
1.47
+13.34%
1.30
Investments And Advances
7.09
0.00
—
—
Long Term Equity Investment
7.09
0.00
—
—
Non Current Prepaid Assets
0.01
-86.96%
0.05
-0.02%
0.05
-6.14%
0.06
Total Liabilities Net Minority Interest
1.00
-71.37%
3.50
+3.78%
3.37
-39.95%
5.61
Current Liabilities
0.80
-72.28%
2.89
-11.85%
3.28
-20.62%
4.13
Payables And Accrued Expenses
0.79
-66.67%
2.38
-20.42%
3.00
-22.12%
3.85
Payables
0.28
-75.98%
1.15
-17.78%
1.40
-29.80%
1.99
Accounts Payable
0.25
-74.27%
0.98
-22.89%
1.28
-28.58%
1.79
Other Payable
—
—
0.12
-40.54%
0.20
Current Accrued Expenses
0.52
-58.00%
1.24
-22.72%
1.60
-13.90%
1.86
Employee Benefits
0.16
-62.97%
0.44
0.00
-100.00%
1.28
Total Tax Payable
0.02
-86.24%
0.16
+36.18%
0.12
-40.54%
0.20
Current Debt And Capital Lease Obligation
0.01
-97.33%
0.27
-4.25%
0.29
-0.55%
0.29
Current Capital Lease Obligation
0.01
-97.33%
0.27
-4.25%
0.29
-0.55%
0.29
Current Deferred Liabilities
0.00
-100.00%
0.23
0.00
0.00
Current Deferred Revenue
0.00
-100.00%
0.23
0.00
0.00
Total Non Current Liabilities Net Minority Interest
0.20
-67.02%
0.60
+593.04%
0.09
-94.10%
1.48
Long Term Debt And Capital Lease Obligation
0.03
-50.71%
0.07
-19.13%
0.09
-55.21%
0.19
Long Term Capital Lease Obligation
0.03
-50.71%
0.07
-19.13%
0.09
-55.21%
0.19
Non Current Pension And Other Postretirement Benefit Plans
0.16
-62.97%
0.44
0.00
-100.00%
1.28
Non Current Deferred Liabilities
0.00
-100.00%
0.09
0.00
—
Non Current Deferred Revenue
0.00
-100.00%
0.09
0.00
—
Stockholders Equity
9.68
+744.83%
1.15
-76.68%
4.91
-70.98%
16.93
Common Stock Equity
9.68
+744.83%
1.15
-76.68%
4.91
-70.98%
16.93
Capital Stock
1.84
+0.00%
1.84
+59.82%
1.15
-97.66%
49.27
Common Stock
1.84
+0.00%
1.84
+59.82%
1.15
-97.66%
49.27
Share Issued
184.35
+0.00%
184.35
+59.82%
115.35
+134.10%
49.27
Ordinary Shares Number
98.34
+3.26%
95.24
+23.47%
77.13
+103.53%
37.90
Treasury Shares Number
86.01
-3.49%
89.12
+133.21%
38.21
+235.96%
11.37
Additional Paid In Capital
266.38
+0.07%
266.19
-1.23%
269.51
-5.10%
283.98
Retained Earnings
-353.36
+1.96%
-360.42
-3.02%
-349.86
-6.32%
-329.06
Gains Losses Not Affecting Retained Earnings
31.06
+4.19%
29.81
+15.70%
25.77
+5.44%
24.44
Treasury Stock
0.87
-4.38%
0.91
-85.51%
6.28
-46.35%
11.70
Other Equity Adjustments
31.06
+4.19%
29.81
+15.70%
25.77
+5.44%
24.44
Total Equity Gross Minority Interest
9.68
+744.83%
1.15
-76.68%
4.91
-70.98%
16.93
Total Capitalization
9.68
+744.83%
1.15
-76.68%
4.91
-70.98%
16.93
Working Capital
2.74
+104.22%
1.34
-70.50%
4.55
-74.47%
17.81
Invested Capital
9.68
+744.83%
1.15
-76.68%
4.91
-70.98%
16.93
Total Debt
0.04
-87.80%
0.34
-7.72%
0.37
-22.59%
0.48
Capital Lease Obligations
0.04
-87.80%
0.34
-7.72%
0.37
-22.59%
0.48
Net Tangible Assets
9.68
+744.83%
1.15
-76.68%
4.91
-70.98%
16.93
Tangible Book Value
9.68
+744.83%
1.15
-76.68%
4.91
-70.98%
16.93
Investmentsin Associatesat Cost
7.09
0.00
—
—
Other Equity Interest
64.62
+0.00%
64.62
+0.00%
64.62
—
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-5.37
+32.77%
-7.99
+51.38%
-16.44
-11.78%
-14.71
Cash Flow From Continuing Operating Activities
-5.37
+32.77%
-7.99
+51.38%
-16.44
-11.78%
-14.71
Net Income From Continuing Operations
7.06
+166.84%
-10.56
+49.26%
-20.80
-35.52%
-15.35
Depreciation Amortization Depletion
0.26
-14.98%
0.31
-5.32%
0.32
-7.04%
0.35
Depreciation
0.26
-14.98%
0.31
-5.32%
0.32
-7.04%
0.35
Depreciation And Amortization
0.26
-14.98%
0.31
-5.32%
0.32
-7.04%
0.35
Other Non Cash Items
0.40
-80.99%
2.11
-45.95%
3.90
+221.81%
1.21
Pension And Employee Benefit Expense
-0.10
-52.00%
-0.06
-449.84%
-0.01
+92.43%
-0.15
Stock Based Compensation
—
—
3.68
+212.48%
1.18
Operating Gains Losses
-11.86
-18835.33%
-0.06
-449.84%
-0.01
+92.43%
-0.15
Gain Loss On Sale Of PPE
—
—
0.00
+100.00%
-0.00
Change In Working Capital
-1.23
-674.66%
0.21
+35.57%
0.16
+120.70%
-0.76
Change In Receivables
0.13
-70.02%
0.45
+263.22%
-0.27
-6.97%
-0.26
Changes In Account Receivables
0.09
-69.62%
0.31
+221.59%
-0.25
-161.47%
-0.10
Change In Prepaid Assets
-0.16
-407.73%
0.05
-93.68%
0.84
+236.95%
-0.62
Change In Payables And Accrued Expense
-1.15
-86.90%
-0.61
-43.48%
-0.43
-148.36%
0.88
Change In Other Working Capital
-0.04
-111.84%
0.32
—
-0.82
Change In Other Current Assets
-0.01
-687.61%
0.00
-83.43%
0.01
-70.74%
0.05
Investing Cash Flow
4.65
+67992.59%
-0.01
-330.22%
0.00
+109.80%
-0.03
Cash Flow From Continuing Investing Activities
4.65
+67992.59%
-0.01
-330.22%
0.00
+109.80%
-0.03
Net PPE Purchase And Sale
-0.00
+81.39%
-0.01
-1077.62%
-0.00
+98.16%
-0.03
Purchase Of PPE
-0.00
+81.39%
-0.01
-1077.62%
-0.00
+98.16%
-0.03
Capital Expenditure
-0.00
+81.39%
-0.01
-1077.62%
-0.00
+98.16%
-0.03
Net Investment Purchase And Sale
0.00
0.00
-100.00%
0.00
+187.46%
0.00
Sale Of Investment
0.00
0.00
-100.00%
0.00
+187.46%
0.00
Net Business Purchase And Sale
-0.47
0.00
0.00
—
Purchase Of Business
-0.47
0.00
0.00
—
Gain Loss On Sale Of Business
-13.94
0.00
0.00
—
Net Other Investing Changes
5.12
—
—
—
Financing Cash Flow
0.10
-98.01%
5.26
+69.68%
3.10
-81.08%
16.40
Cash Flow From Continuing Financing Activities
0.10
-98.01%
5.26
+69.68%
3.10
-81.08%
16.40
Net Issuance Payments Of Debt
-0.07
+73.85%
-0.28
+2.18%
-0.29
+6.96%
-0.31
Repayment Of Debt
-0.07
+73.85%
-0.28
+2.18%
-0.29
+6.96%
-0.31
Long Term Debt Payments
-0.07
+73.85%
-0.28
+2.18%
-0.29
+6.96%
-0.31
Net Long Term Debt Issuance
-0.07
+73.85%
-0.28
+2.18%
-0.29
+6.96%
-0.31
Net Common Stock Issuance
0.24
-89.79%
2.34
+40.01%
1.67
-88.02%
13.96
Common Stock Payments
-0.00
+80.29%
-0.01
-156.61%
-0.00
-950.30%
-0.00
Cash Dividends Paid
0.00
0.00
0.00
0.00
Repurchase Of Capital Stock
-0.00
+80.29%
-0.01
-156.61%
-0.00
-950.30%
-0.00
Proceeds From Stock Option Exercised
-0.04
-101.12%
3.26
+42.12%
2.29
-58.13%
5.47
Net Other Financing Charges
-0.01
+48.32%
-0.03
+94.51%
-0.52
+80.28%
-2.65
Changes In Cash
-0.62
+77.20%
-2.73
+79.49%
-13.33
-899.58%
1.67
Effect Of Exchange Rate Changes
0.10
+127.93%
-0.36
-81.91%
-0.20
-260.22%
0.12
Beginning Cash Position
3.87
-44.44%
6.96
-66.04%
20.48
+9.57%
18.70
End Cash Position
3.34
-13.55%
3.87
-44.44%
6.96
-66.04%
20.48
Free Cash Flow
-5.37
+32.81%
-8.00
+51.34%
-16.44
-11.54%
-14.74
Common Stock Issuance
0.24
-89.75%
2.35
+40.26%
1.68
-87.99%
13.96
Earnings Losses From Equity Investments
2.18
0.00
0.00
—
Interest Paid CFF
-0.01
+57.33%
-0.02
+55.81%
-0.05
+22.40%
-0.06
Issuance Of Capital Stock
0.24
-89.75%
2.35
+40.26%
1.68
-87.99%
13.96
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category